Recruiting NA Children With Cerebral Palsy

New treatment option for Children With Cerebral Palsy

Official title Trunk Activity Rehabilitation in Young Children With Cerebral Palsy

ClinicalTrials.gov ID: NCT06438432

What this study is testing

What it's testing
Children with CP exhibit trunk control issues from early childhood, affecting their balance and gait. These issues manifest as unstable walking, increased step width, and more pronounced anterior deceleration of the sternum.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 6. Healthy volunteers may be eligible.

You may be able to join if

  • For children with CP
  • Age between 18 months and 5 years 6 months
  • CP type: spastic paraparesis or spastic hemiparesis, GMFCS I to II
  • No or moderate retraction of the sural triceps (ankle dorsiflexion: \> 5° on clinical examination, knee straight)
  • Sufficient level of understanding to carry out activities involving the trunk in the form of self-exercises (rehabilitation protocol), as well as...

You likely can't join if

  • For children with CP
  • Previous surgery on lower limbs less than 1 year ago
  • Botulinum toxin A injection less than 6 months ago
  • Any change in rehabilitative and/or orthopedic management in the last 2 months
  • Hip flessum \> 20
  • Presence of subacute or chronic pain on standing or walking For children with DT \- Neurological and/or orthopedic disorders that may influence gait
See the full eligibility criteria
Who can join
  • For children with CP
  • Age between 18 months and 5 years 6 months
  • CP type: spastic paraparesis or spastic hemiparesis, GMFCS I to II
  • No or moderate retraction of the sural triceps (ankle dorsiflexion: \> 5° on clinical examination, knee straight)
  • Sufficient level of understanding to carry out activities involving the trunk in the form of self-exercises (rehabilitation protocol), as well as clinical assessments and functional explorations.
  • Acceptance by the physiotherapist in charge of the child's follow-up to collaborate in carrying out the RAIT.
  • Affiliated with a social security scheme For children with DT
  • Age between 18 months and 5 years 6 months
  • Walking acquired before age 18 months
  • Sufficient level of understanding to perform clinical assessments and functional explorations
  • Affiliated with a social security scheme
What rules you out
  • For children with CP
  • Previous surgery on lower limbs less than 1 year ago
  • Botulinum toxin A injection less than 6 months ago
  • Any change in rehabilitative and/or orthopedic management in the last 2 months
  • Hip flessum \> 20
  • Presence of subacute or chronic pain on standing or walking For children with DT \- Neurological and/or orthopedic disorders that may influence gait

The study team makes the final eligibility decision.

Where it's taking place

  • Nancy, France

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 months to 6 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Nancy, France. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.